DALLAS, Feb. 14, 2012 /PRNewswire/ -- Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor, LLP are investigating the sale of SeraCare Life Sciences, Inc. ("SeraCare" or "SRLS") (NASDAQ: SRLS) to an affiliate of Linden Capital Partners for shareholders.  Under the proposed transaction, SeraCare shareholders will receive $4.00 in cash for each share of SeraCare/SRLS stock owned, which is well below the target price of $5.00 per share announced by analysts.

(Logo: http://photos.prnewswire.com/prnh/20111111/DA05320LOGO)

If you are an affected investor, and you want to learn more about the lawsuit or join the action, contact Patrick Powers at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at patrick@powerstaylor.com, or Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 706-9314, or via email at WBriscoe@TheBriscoeLawFirm.com.  There is no cost or fee to you.

The definitive merger agreement involves an all cash transaction with a total equity value of approximately $82 million.  The deal is expected to close in the second quarter of calendar year 2012.

The investigation centers on whether SeraCare shareholders are receiving adequate compensation for their shares in the buyout, whether the transaction undervalues SeraCare stock, and whether SeraCare's board attempted to obtain the highest share price for all shareholders prior to agreeing to the deal.  Although the acquisition price represents an approximate 11% premium over the closing price of SeraCare shares the day prior to the buyout announcement, SeraCare shares closed as high as $4.15 per share as recently as July 19, 2011.  Further, according to Yahoo! Finance, at least one analyst has reported that the true inherent value of SeraCare shares may be as high as $5.00 per share. According to shareholder rights attorney Willie Briscoe, "Because of the lack of a significant premium to the shareholders and the company's rising historic share value, among other factors, we believe that the transaction may significantly undervalue SeraCare stock.  Our lawsuit will seek to obtain the highest share price for all shareholders."

The Briscoe Law Firm, PLLC is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Powers Taylor, LLP is a boutique litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.

 

 

 

SOURCE Powers Taylor, LLP

Copyright 2012 PR Newswire

Seracare Life Sciences (NASDAQ:SRLS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Seracare Life Sciences.
Seracare Life Sciences (NASDAQ:SRLS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Seracare Life Sciences.